Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Medivir and Rheos Medicines divulge new MALT1 inhibitors

May 13, 2022

Rheinische Friederich-Wilhelms-Universitaet Bonn discloses MRGPRX4 agonists

May 11, 2022

Sunshine Lake Pharma patents new GNRHR antagonists

April 22, 2022

Soltego discloses new SIK inhibitors

April 8, 2022

Can-Fite developing topical formulation of piclidenoson for the treatment of psoriasis

April 6, 2022

Novel TLR4 murine model to study dermal sensitization by nickel salts

April 4, 2022

PF-07038124: a topical PDE4 inhibitor for atopic dermatitis and plaque psoriasis

March 29, 2022

Seoul National University Hospital patents triglyceride-lowering peptides

March 29, 2022

Dompe Farmaceutici describes new peptides with angiogenic activity

March 28, 2022

Sichuan Good Doctor Panxi Pharmaceutical describes new wound-healing polypeptides

March 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...